Alcon AG | ALC - Operating Profit

Stock Price
61.30
Daily Change
-0.12 -0.20%
Monthly
-6.01%
Yearly
-26.66%
Q1 Forecast
60.90

Alcon AG reported $332M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AstraZeneca USD -1.5B 5.01B Sep/2025
Bayer EUR -543M 556M Sep/2025
Essilor EUR 2B 1.22B Jun/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 449.94M 18.94M Sep/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 2.57M Sep/2025
Lonza CHF 430M 104M Dec/2024
Merck EUR 1.21B 180M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Philips EUR 329M 159M Sep/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Smith & Nephew USD 440M 50M Dec/2025
Sonova Holding CHF 296.8M 156.9M Dec/2025
UCB EUR 1B 678M Dec/2024